1
项与 Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology ) 相关的临床试验Autologous Immunotherapy With Multi-target Gene-modified CAR-T/TCR-T Cell for Malignancies
This is a single arm, open-label, uni-center, phase I-II study to evaluate the safety and effectiveness of CAR-T/TCR-T cell immunotherapy in treating with different malignancies patients.
100 项与 Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology ) 相关的临床结果
100 项与 Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology ) 相关的转化医学
100 项与 Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology ) 相关的专利(医药)
100 项与 Multi-target Gene-modified CAR-T/TCR-T Cell (Shenzhen Binde Biotechnology ) 相关的药物交易